Table 2. Antibiotic resistance of the 157 ST398-MRSA isolates from the three groups of pigs.
Total | Group 1 [2] [Farm B; 2016; AMX+COL]a |
Group 2 [Farm B; 2018; AMX]a |
Group 3 [Farm C; 2018; none]a |
|
---|---|---|---|---|
Total collection | 157 | 58 | 48 | 51 |
FOX | 157 (100%) | 58 (100%) | 48 (100%) | 51 (100%) |
ERY | 106 (68%) | 58 (100%)* | 46 (96%)* | 2 (4%)* |
CLIN | 155 (99%) | 58 (100%) | 48 (100%) | 49 (96%) |
CIP | 67 (43%) | 22 (38%) | 42 (88%)* | 3 (6%)* |
TET | 157 (100%) | 58 (100%) | 48 (100%) | 51 (100%) |
SXT | 114 (73%) | 31 (53%)* | 44 (92%)* | 39 (76%) |
GEN | 54 (34%) | 29 (50%) | 2 (4%)* | 23 (45%) |
QD | 156 (99%) | 58 (100%) | 48 (100%) | 50 (98%) |
CHL | 52 (33%) | 51 (88%)* | 1 (2%)* | 0* |
spa t011 | 108 | 22 | 38 | 48 |
FOX | 108 (100%) | 22 (100%) | 38 (100%) | 48 (100%) |
ERY | 60 (56%) | 22 (100%)* | 36 (95%)* | 2 (4%)* |
CLIN | 106 (98%) | 22 (100%) | 38 (100%) | 46 (96%) |
CIP | 63 (58%) | 22 (100%)* | 38 (100%)* | 3 (6%)* |
TET | 108 (100%) | 22 (100%) | 38 (100%) | 48 (100%) |
SXT | 99 (92%) | 22 (100%) | 38 (100%) | 39 (81%)* |
GEN | 22 (20%) | 0* | 0* | 22 (46%) |
QD | 107 (99%) | 22 (100%) | 38 (100%) | 47 (98%) |
CHL | 15 (14%) | 15 (68%)* | 0* | 0* |
spa t108 | 45 | 36 | 6 | 3 |
FOX | 45 (100%) | 36 (100%) | 6 (100%) | 3 (100%) |
ERY | 41 (91%) | 36 (100%)* | 5 (83%) | 0* |
CLIN | 45 (100%) | 36 (100%) | 6 (100%) | 3 (100%) |
CIP | 0 (0%) | 0* | 0* | 0* |
TET | 45 (100%) | 36 (100%) | 6 (100%) | 3 (100%) |
SXT | 11 (24%) | 9 (25%) | 2 (33%) | 0* |
GEN | 32 (71%) | 29 (81%)* | 2 (33%) | 1 (33%) |
QD | 45 (100%) | 36 (100%)* | 6 (100%) | 3 (100%) |
CHL | 37 (82%) | 36 (100%)* | 1 (17%)* | 0* |
FOX–Cefoxitin; ERY–Erythromycin; CLIN–Clindamycin; CIP–Ciprofloxacin; TET–Tetracycline; SXT–Trimethoprim-sulfamethoxazole; GEN–Gentamicin; QD–Quinupristin-dalfopristin; CHL–Chloramphenicol.
aAntibiotics included in the feed regimen. AMX–Amoxicillin; COL–Colistin.
*Significant difference (p<0.01).
Numbers in bold indicate that ≥50% of the isolates are resistant to the antibiotic.